AVRICORE HEALTH INC.

Avricore Health (TSX-V:AVCR, OTC:AVCRF) said it grew the number of pharmacy locations offering HealthTab during the third quarter of 2023, which led to an increase in revenue. In the three months ending September 30, 2023, revenue increased by 27% YoY to $953,454, with a gross profit rise of 21% to $261,778. » Mehr auf proactiveinvestors.com

Avricore Health (TSX-V:AVCR, OTC:AVCRF) said it in the first half of 2023 it continues to surpass financial targets, strike partnerships, and develop new markets as it brings its turkey solution for point-of-care testing HealthTab to additional pharmacies across Canada and internationally. The company noted that its first-half earnings were up 437% at $1,177,290 compared to the same period last year with more HealthTab systems deployed and tets sold. » Mehr auf proactiveinvestors.com

Avricore Health (TSX-V:AVCR, OTC:AVCRF) Inc has announced the signing of a reseller agreement between HealthTab Inc, the company's point-of-care testing solution, and Abbott Rapid Dx UK & Ireland.  The pharmacy service innovator said the agreement provides a foundation for HealthTab to purchase and distribute the Afinion 2 and associated tests for diabetes and heart disease screening in community pharmacies in the UK. » Mehr auf proactiveinvestors.com